Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Advanced Gastric Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1703 Neoplasms 1223 Carcinoma, Non-Small-Cell Lung 1109 Prostatic Neoplasms 914 Multiple Myeloma 707 Leukemia, Myeloid, Acute 638 Neoplasm Metastasis 599 Colorectal Neoplasms 592 Lung Neoplasms 583 Melanoma 563 Lymphoma 538 Leukemia 496 Lymphoma, Non-Hodgkin 476 Ovarian Neoplasms 449 Leukemia, Lymphocytic, Chronic, B-Cell 444 Pancreatic Neoplasms 422 Precursor Cell Lymphoblastic Leukemia-Lymphoma 404 Recurrence 388 Myelodysplastic Syndromes 350 Carcinoma, Renal Cell 346 Lymphoma, Follicular 345 Head and Neck Neoplasms 328 Brain Neoplasms 318 Glioblastoma 317 Lymphoma, Large B-Cell, Diffuse 310 Carcinoma, Hepatocellular 282 Hodgkin Disease 280 Squamous Cell Carcinoma of Head and Neck 261 Lymphoma, Mantle-Cell 255 Colonic Neoplasms 235

Interventions

rucaparib 1 relatlimab 1 linrodostat 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02935634 2023-06-09

FRACTION-GC

Bristol-Myers Squibb

Phase 2 Completed

190 enrolled 25 charts

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡